These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 22980642)
1. Process scale separation of an anti-CD22 immunotoxin charge variant. Linke T; Feng J; Yu K; Kim HJ; Wei Z; Wang Y; Wang WK; Hunter AK J Chromatogr A; 2012 Oct; 1260():120-5. PubMed ID: 22980642 [TBL] [Abstract][Full Text] [Related]
2. Expression and purification of recombinant immunotoxin--a fusion protein stabilizes a single-chain Fv (scFv) in denaturing condition. Kim SH Protein Expr Purif; 2003 Jan; 27(1):85-9. PubMed ID: 12509988 [TBL] [Abstract][Full Text] [Related]
3. The immunotoxin activity of exotoxin A is sensitive to domain modifications. Amiri Tehranizadeh Z; Sankian M; Fazly Bazzaz BS; Chamani J; Mehri S; Baratian A; Saberi MR Int J Biol Macromol; 2019 Aug; 134():1120-1131. PubMed ID: 31129209 [TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of fusion protein truncated Pseudomonas Exotoxin A (PE38KDEL) in Escherichia coli. Song S; Xue J; Fan K; Kou G; Zhou Q; Wang H; Guo Y Protein Expr Purif; 2005 Nov; 44(1):52-7. PubMed ID: 15922623 [TBL] [Abstract][Full Text] [Related]
5. Design of a modular immunotoxin connected by polyionic adapter peptides. Kleinschmidt M; Rudolph R; Lilie H J Mol Biol; 2003 Mar; 327(2):445-52. PubMed ID: 12628249 [TBL] [Abstract][Full Text] [Related]
6. Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A. Akbari B; Farajnia S; Zarghami N; Mahdieh N; Rahmati M; Khosroshahi SA; Barzegar A; Rahbarnia L Anticancer Drugs; 2017 Mar; 28(3):263-270. PubMed ID: 27861173 [TBL] [Abstract][Full Text] [Related]
7. Increased affinity and stability of an anti-HIV-1 envelope immunotoxin by structure-based mutagenesis. McHugh L; Hu S; Lee BK; Santora K; Kennedy PE; Berger EA; Pastan I; Hamer DH J Biol Chem; 2002 Sep; 277(37):34383-90. PubMed ID: 12119300 [TBL] [Abstract][Full Text] [Related]
8. Recombinant anti-EGFR immunotoxin 425(scFv)-ETA' demonstrates anti-tumor activity against disseminated human pancreatic cancer in nude mice. Bruell D; Bruns CJ; Yezhelyev M; Huhn M; Müller J; Ischenko I; Fischer R; Finnern R; Jauch KW; Barth S Int J Mol Med; 2005 Feb; 15(2):305-13. PubMed ID: 15647848 [TBL] [Abstract][Full Text] [Related]
9. Modular Conjugation of a Potent Anti-HER2 Immunotoxin Using Coassociating Peptides. Stoessel A; Groysbeck N; Guyot L; Barret L; Nominé Y; Nguekeu-Zebaze L; Bender A; Voilquin L; Lutz T; Pallaoro N; Blocat M; Deville C; Masson M; Zuber G; Chatton B; Donzeau M Bioconjug Chem; 2020 Oct; 31(10):2421-2430. PubMed ID: 32996763 [TBL] [Abstract][Full Text] [Related]
10. Peptide-Directed Photo-Cross-Linking for Site-Specific Conjugation of IgG. Park J; Lee Y; Ko BJ; Yoo TH Bioconjug Chem; 2018 Oct; 29(10):3240-3244. PubMed ID: 30179444 [TBL] [Abstract][Full Text] [Related]
11. Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A. Kaplan G; Lee F; Onda M; Kolyvas E; Bhardwaj G; Baker D; Pastan I Toxins (Basel); 2016 Jul; 8(8):. PubMed ID: 27463727 [TBL] [Abstract][Full Text] [Related]
12. Designing the furin-cleavable linker in recombinant immunotoxins based on Pseudomonas exotoxin A. Weldon JE; Skarzynski M; Therres JA; Ostovitz JR; Zhou H; Kreitman RJ; Pastan I Bioconjug Chem; 2015 Jun; 26(6):1120-8. PubMed ID: 25997032 [TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy. Chen H; Gao J; Lu Y; Kou G; Zhang H; Fan L; Sun Z; Guo Y; Zhong Y J Control Release; 2008 Jun; 128(3):209-16. PubMed ID: 18450313 [TBL] [Abstract][Full Text] [Related]
14. A recombinant immunotoxin derived from a humanized epithelial cell adhesion molecule-specific single-chain antibody fragment has potent and selective antitumor activity. Di Paolo C; Willuda J; Kubetzko S; Lauffer I; Tschudi D; Waibel R; Plückthun A; Stahel RA; Zangemeister-Wittke U Clin Cancer Res; 2003 Jul; 9(7):2837-48. PubMed ID: 12855664 [TBL] [Abstract][Full Text] [Related]
15. A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies. Buchner J; Pastan I; Brinkmann U Anal Biochem; 1992 Sep; 205(2):263-70. PubMed ID: 1332541 [TBL] [Abstract][Full Text] [Related]
16. Assessment of the impact of manufacturing changes on the physicochemical properties of the recombinant vaccine carrier ExoProtein A. Burkhardt M; Reiter K; Nguyen V; Suzuki M; Herrera R; Duffy PE; Shimp R; MacDonald NJ; Olano LR; Narum DL Vaccine; 2019 Sep; 37(38):5762-5769. PubMed ID: 30262247 [TBL] [Abstract][Full Text] [Related]
17. Independent domain folding of Pseudomonas exotoxin and single-chain immunotoxins: influence of interdomain connections. Brinkmann U; Buchner J; Pastan I Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3075-9. PubMed ID: 1557415 [TBL] [Abstract][Full Text] [Related]
18. Influence of structural variations on biological activity of anti-PSMA scFv and immunotoxins targeting prostate cancer. Bühler P; Wetterauer D; Gierschner D; Wetterauer U; Beile UE; Wolf P Anticancer Res; 2010 Sep; 30(9):3373-9. PubMed ID: 20944111 [TBL] [Abstract][Full Text] [Related]
19. Affinity purification and characterization of anti-Tac(Fv)-C3-PE38KDEL: A highly potent cytotoxic agent specific to cells bearing IL-2 receptors. Spence C; Nachman M; Gately MK; Kreitman RJ; Pastan I; Bailon P Bioconjug Chem; 1993; 4(1):63-8. PubMed ID: 8431514 [TBL] [Abstract][Full Text] [Related]
20. A bivalent disulfide-stabilized Fv with improved antigen binding to erbB2. Bera TK; Onda M; Brinkmann U; Pastan I J Mol Biol; 1998 Aug; 281(3):475-83. PubMed ID: 9698563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]